VIPR1 antibody (C-Term)
Quick Overview for VIPR1 antibody (C-Term) (ABIN1881994)
Target
See all VIPR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 305-334, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This VIPR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 305-334 amino acids from the C-terminal region of human VIPR1.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Expiry Date
- 6 months
-
-
-
: "Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1." in: Cancer investigation, Vol. 28, Issue 5, pp. 487-94, (2010) (PubMed).
: "Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients." in: Peptides, Vol. 31, Issue 4, pp. 603-8, (2010) (PubMed).
-
-
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Alternative Name
- VIPR1
-
Background
- This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase.
-
Molecular Weight
- 51547
-
NCBI Accession
- NP_001238811, NP_001238812, NP_001238813, NP_001238814, NP_004615
-
UniProt
- P32241
Target
-